Loading clinical trials...
Loading clinical trials...
Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin
Conditions
Interventions
Avelumab
Locations
21
Italy
Istituto Tumori "Giovanni Paolo II" IRCCS Ospedale Oncologico di Bari
Bari, Italy
ASST Papa Giovanni XXIII
Bergamo, Italy
Ospedale Santa Croce - A.O. Ospedali Riuniti Marche Nord
Fano, Italy
IRCCS Ospedale Policlinico San Martino
Genova, Italy
Ospedale di Macerata - ASUR - Area Vasta N°3
Macerata, Italy
Istituto Europeo di Oncologia
Milan, Italy
Start Date
February 6, 2019
Primary Completion Date
September 15, 2021
Completion Date
September 15, 2021
Last Updated
February 1, 2024
Lead Sponsor
Consorzio Oncotech
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions